--NOTICE OF INTENT TO AWARD A SOLE SOURCE CONTRACT TO BIOVERIS CORPORATION TO PROVIDE ANTHAX SPORE TEST KITS TO OPERATE THE M8 ASSAY DEVELOPMENT WORKSTATION AND PERFORM REQUIRED ANALYSIS.

The contract pertains to the award of a sole source agreement to BioVeris Corporation for the supply of Anthrax spore test kits designed for use with the M8 Assay Development Workstation, alongside conducting the necessary analyses. BioVeris Corporation specializes in developing and marketing biological detection systems utilizing their proprietary electrochemiluminescent technology, known as BVtm detection technology, which offers high sensitivity, reliability, speed, and flexibility. Their technology is integrated into instrument systems, tests, and reagents, and is supported by a broad patent portfolio covering diagnostic and biological applications worldwide. This notice of intent, issued by the Department of Defense, specifically through the W6QK Acc-apg Director office, is not a solicitation or request for competitive proposals but an announcement of intent to award. The contract is aligned with NAICS code 334511, which corresponds to search, detection, and navigation instruments. The point of contact for this action is Irene Mancuso, a contract specialist reachable via phone or email. The contract supports the Department of Defense’s efforts by ensuring the provision of advanced and reliable test kits critical for anthrax detection, emphasizing the strategic importance and specialized nature of the procurement.